710-1045

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-06-03

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-03 (study day 62.0); relationship: POSSIBLE

mild assessed

Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-08-03 (study day 62.0); relationship: POSSIBLE

mild assessed

Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-02 (study day 30.0); relationship: NONE

mild assessed

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-07-02 (study day 30.0); relationship: NONE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-02 (study day 30.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-07-02 (study day 30.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-22 (study day 50.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-07-22 (study day 50.0); relationship: POSSIBLE

moderate assessed

Moderate SKIN EXFOLIATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day 72.0); relationship: POSSIBLE

moderate assessed

Moderate SKIN EXFOLIATION — outcome: RECOVERED/RESOLVED; onset 2013-08-13 (study day 72.0); relationship: POSSIBLE

mild assessed

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-02 (study day 30.0); relationship: POSSIBLE

mild assessed

Mild SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-07-02 (study day 30.0); relationship: POSSIBLE

mild assessed

Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-06-22 (study day 20.0); relationship: REMOTE

Data queries

No data queries.